Who is the CEO of ANAB? | Glauxie AI

Q: Who is the CEO of ANAB?

AnaptysBio, Inc. (ANAB) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Daniel R. Faga. AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an... Employees: 104.

Q: What does ANAB company do?

Learn what ANAB does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling ANAB?

Track recent insider buys and sells for ANAB with transaction details, amounts, and trends.

Q: What sector is ANAB in?

Find ANAB sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of ANAB?

🦉

AnaptysBio, Inc. (ANAB)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEODaniel R. Faga

AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various...

Key Executives

Name	Title
Benjamin Stone	Chief Business Officer
Beth Mueller	Senior Vice President of Human Resources
Cailin Sibley FACR	Senior Vice President of Translational Medicine
Christopher Murphy	Chief Financial Officer
Daniel R. Faga	President, Chief Executive Officer & Director
David McKeon	Senior Vice President & Controller

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

ANAB Profile Financials

What does ANAB company do? Are insiders buying or selling ANAB? What sector is ANAB in?